The arrival of this medication in Oz is generating significant buzz within the weight loss community. This novel dual agonist – acting on both GLP-1 and GIP receptors – presents a potentially powerful tool for https://australianpeptidestore.co/bpc-157-10mg-research-peptide-australian-peptide-store/